Stribild

Gilead Advancing Access Patient Assistance Program Patient Guide: How to Get Stribild at Low or No Cost

Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) is a prescription medication used to treat HIV-1 infection in adults and children who weigh at least 35 kg. It combines four antiretroviral drugs in one pill taken once daily, helping to control the virus, prevent progression to AIDS, and reduce transmission risk when viral load is undetectable. This guide explains how the Gilead Advancing Access Patient Assistance Program (PAP/MAP) can provide Stribild free of charge if you qualify, making treatment accessible for those facing financial barriers.

Who Qualifies for the Program?

The program is designed for uninsured or underinsured U.S. residents (including Puerto Rico and U.S. Territories) who cannot afford their Gilead medications like Stribild. Key eligibility includes:

• Residing in the U.S., Puerto Rico, or U.S. Territories (proof may be required).
• Meeting income limits at or below 500% of the Federal Poverty Level (FPL).
• Lacking prescription coverage or having insurance that doesn't cover Stribild.
• Having a valid prescription from a licensed healthcare provider.

Government insurance like Medicare, Medicaid, or VA benefits may disqualify you in some cases—check details below. Enrollment lasts up to 12 months, with ongoing checks to confirm you still qualify. If your situation changes (e.g., you gain insurance), assistance may end.

About Stribild

Stribild is a complete HIV regimen in one tablet, containing:

• Elvitegravir: An integrase strand transfer inhibitor (INSTI) that blocks HIV from integrating its DNA into your cells.
• Cobicistat: Boosts elvitegravir's effectiveness by inhibiting an enzyme that breaks it down.
• Emtricitabine: A nucleoside reverse transcriptase inhibitor (NRTI) that prevents HIV replication.
• Tenofovir disoproxil fumarate: Another NRTI that interferes with HIV's ability to multiply.

Taken with food once daily, it suppresses HIV viral load effectively for many patients. Common side effects include nausea, diarrhea, and kidney issues—discuss with your doctor. Always follow your provider's instructions; do not skip doses to avoid resistance.

Income Eligibility Breakdown

Eligibility hinges on household income at or below 500% of the FPL for uninsured/underinsured patients. FPL guidelines adjust yearly; use the table below for 2026 estimates (verify current levels via HHS.gov or call the program).

Notes: Include all household income sources. Provide proof like tax returns, W-2s, or pay stubs. Program verifies via credit bureaus with consent.

Insurance Requirements

• Uninsured: Fully eligible if income-qualified.
• Underinsured: Eligible if insurance lacks prescription coverage for Stribild.
• Exclusions: Often ineligible with Medicare, Medicaid, TRICARE, VA, or state programs like ADAP (unless specified). Commercial insurance may qualify for co-pay help instead via the Co-pay Savings Program.

Contact (800) 226-2056 (Mon-Fri, 9 AM-8 PM ET) to confirm your status. Benefits investigations can check coverage.

Step-by-Step Application Process

1. Get a Prescription: Ask your doctor for Stribild and have them complete the provider section.
2. Choose Application Method (multiple options):
   • Call: Dial (800) 226-2056 for guidance.
   • Online: Enroll at GileadAdvancingAccess.com (immediate eligibility check possible).
   • Download & Fax: Get English/Spanish forms, complete, fax to number on form (reviewed in ~2 business days).
3. Gather Documents:
   • Proof of income (e.g., last two pay stubs, tax return, W-2).
   • Proof of residency (e.g., utility bill, ID).
   • Proof of insurance status (e.g., denial letter).
   • Prescription.
4. Sign & Submit: Patient and doctor sign; authorize info sharing for verification.
5. Follow Up: Expect a call from a specialist. They'll confirm next steps.

A specialist may contact you post-submission.

Timeline and Delivery

• Review Time: Online—instant possible; fax/call—~2 business days.
• Approval Notification: Via phone (preferred), mail, or your listed method.
• Delivery: Shipped free to your home via mail order (as of May 5, 2025). Up to 12 months' supply initially.

Reauthorization: Required annually or if status changes. Ongoing checks ensure eligibility.

Alternatives if Denied

• Appeal: Call (800) 226-2056 to discuss reasons and resubmit.
• Co-pay Program: For commercially insured (if applicable).
• Other Resources: State ADAP, Ryan White programs, or patient access networks like PAN Foundation.
• Generics/Biosimilars: None listed for Stribild currently.
• Doctor Assistance: Providers can use HCP portal for benefits help or prior authorizations.

Disclaimer

This guide is for informational purposes only and not medical/financial advice. Program details can change; Gilead may modify, discontinue, or terminate at any time without notice. Verify eligibility and rules by calling (800) 226-2056 or visiting GileadAdvancingAccess.com. Consult your healthcare provider for treatment decisions. Income tables are estimates—use official FPL charts. Assistance not guaranteed.